155 related articles for article (PubMed ID: 28747518)
1. Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog.
Baiu DC; Marsh IR; Boruch AE; Shahi A; Bhattacharya S; Jeffery JJ; Zhao Q; Hall LT; Weichert JP; Bednarz BP; Otto M
J Nucl Med; 2018 Feb; 59(2):244-250. PubMed ID: 28747518
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Pharmacokinetics and Dosimetry Studies of
Marsh IR; Grudzinski J; Baiu DC; Besemer A; Hernandez R; Jeffery JJ; Weichert JP; Otto M; Bednarz BP
J Nucl Med; 2019 Oct; 60(10):1414-1420. PubMed ID: 30926646
[TBL] [Abstract][Full Text] [Related]
3. Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404.
Besemer AE; Titz B; Grudzinski JJ; Weichert JP; Kuo JS; Robins HI; Hall LT; Bednarz BP
Phys Med Biol; 2017 Jul; 62(15):6008-6025. PubMed ID: 28682793
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.
Morris ZS; Weichert JP; Saker J; Armstrong EA; Besemer A; Bednarz B; Kimple RJ; Harari PM
Radiother Oncol; 2015 Sep; 116(3):504-9. PubMed ID: 26123834
[TBL] [Abstract][Full Text] [Related]
5. Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma.
Marino R; Baiu DC; Bhattacharya S; Titz B; Hebron E; Menapace BD; Singhal S; Eickhoff JC; Asimakopoulos F; Weichert JP; Otto M
Am J Cancer Res; 2015; 5(11):3422-35. PubMed ID: 26807322
[TBL] [Abstract][Full Text] [Related]
6. A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety.
Grudzinski JJ; Titz B; Kozak K; Clarke W; Allen E; Trembath L; Stabin M; Marshall J; Cho SY; Wong TZ; Mortimer J; Weichert JP
PLoS One; 2014; 9(11):e111652. PubMed ID: 25402488
[TBL] [Abstract][Full Text] [Related]
7. A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies.
Lubner SJ; Mullvain J; Perlman S; Pishvaian M; Mortimer J; Oliver K; Heideman J; Hall L; Weichert J; Liu G
Cancer Invest; 2015; 33(10):483-9. PubMed ID: 26536061
[TBL] [Abstract][Full Text] [Related]
8. [
Hall LT; Titz B; Baidya N; van der Kolk AG; Robins HI; Otto M; Perlman SB; Weichert JP; Kuo JS
Mol Imaging Biol; 2020 Apr; 22(2):434-443. PubMed ID: 31183841
[TBL] [Abstract][Full Text] [Related]
9. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.
Weichert JP; Clark PA; Kandela IK; Vaccaro AM; Clarke W; Longino MA; Pinchuk AN; Farhoud M; Swanson KI; Floberg JM; Grudzinski J; Titz B; Traynor AM; Chen HE; Hall LT; Pazoles CJ; Pickhardt PJ; Kuo JS
Sci Transl Med; 2014 Jun; 6(240):240ra75. PubMed ID: 24920661
[TBL] [Abstract][Full Text] [Related]
10. PET/CT imaging of the diapeutic alkylphosphocholine analog
Hall LT; Titz B; Robins HI; Bednarz BP; Perlman SB; Weichert JP; Kuo JS
Am J Nucl Med Mol Imaging; 2017; 7(4):157-166. PubMed ID: 28913154
[TBL] [Abstract][Full Text] [Related]
11. Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry.
Marsh IR; Li C; Grudzinski J; Jeffery J; Longhurst C; Adam DP; Hernandez R; Weichert JP; Harari PM; Bednarz BP
Cancer Biother Radiopharm; 2023 Sep; 38(7):458-467. PubMed ID: 37022739
[No Abstract] [Full Text] [Related]
12. Phospholipid ether analogs for the detection of colorectal tumors.
Deming DA; Maher ME; Leystra AA; Grudzinski JP; Clipson L; Albrecht DM; Washington MK; Matkowskyj KA; Hall LT; Lubner SJ; Weichert JP; Halberg RB
PLoS One; 2014; 9(10):e109668. PubMed ID: 25286226
[TBL] [Abstract][Full Text] [Related]
13. CLR 125 Auger Electrons for the Targeted Radiotherapy of Triple-Negative Breast Cancer.
Grudzinski J; Marsh I; Titz B; Jeffery J; Longino M; Kozak K; Lange K; Larrabee J; Weichmann A; Moser A; Bednarz B
Cancer Biother Radiopharm; 2018 Apr; 33(3):87-95. PubMed ID: 29641256
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog.
Elsaid MY; Shahi A; Wang AR; Baiu DC; Li C; Werner LR; Singhal S; Hall LT; Weichert JP; Armstrong EA; Bednarz BP; Harari PM; Iyer G; Otto M
Mol Cancer Ther; 2018 Nov; 17(11):2320-2328. PubMed ID: 30108133
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship effects on the tumor avidity of radioiodinated phospholipid ether analogues.
Pinchuk AN; Rampy MA; Longino MA; Skinner RW; Gross MD; Weichert JP; Counsell RE
J Med Chem; 2006 Apr; 49(7):2155-65. PubMed ID: 16570911
[TBL] [Abstract][Full Text] [Related]
17. The radiobiology of targeted radiotherapy.
Wheldon TE; O'Donoghue JA
Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
[TBL] [Abstract][Full Text] [Related]
18. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature.
Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN
Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors.
Yamaguchi A; Hanaoka H; Higuchi T; Tsushima Y
J Nucl Med; 2018 May; 59(5):815-821. PubMed ID: 29217738
[No Abstract] [Full Text] [Related]
[Next] [New Search]